Stop looking for answers,
innovate with the right partner

Novel technologies, great startups and innovative business opportunities at one click. Meet brilliant experts worldwide.

Popular on Innoget

Stefano Resta from Fater SpA

Seeking Glue-free and Plastic-free closure of paper packaging

  • Read
  • Posted by Stefano Resta from Fater SpA
  • ·
  • Project Size : 50,000 - 250,000 €

We are looking for a technology to seal paper packaging materials (paper only with no plastic coating) without using traditional glues or any other additive. For a sustainable packaging application, we're looking for a technology to seal or crimp kraft paper without using glue or plastic coating applied on the paper. Ideally, we want to seal 100% untreated paper without adding any other chemicals. Our preferred solution would be a folding of the packaging material

PepsiCo

Seeking Recycling technologies for biodegradable films

  • Read
  • Posted by PepsiCo
  • ·
  • Deadline : 2024-06-11

We are looking for solutions to convert bio-based packaging back to starting materials or other high-value added chemicals (no fuels).

PepsiCo

Seeking Recyclable Closure for Paper Beverage Bottles

  • Read
  • Posted by PepsiCo
  • ·
  • Deadline : 1970-01-01

We are seeking technologies for a re-closable fiber-based closure for a paper beverage bottle that can be recycled in the paper stream.

Radoslaw Rudz from Jagiellonian University

Improving stem cell culture using carnivorous plants

  • Read
  • Posted by Radoslaw Rudz from Jagiellonian University
  • ·
  • Patents for licensing

Mesenchymal Stem Cells (MSCs) are multipotent precursor cells with the unique capacity to self-renew, proliferation and transformation into specialized cells present in many body tissues, such as muscle, adipose tissue, fibroblasts, cartilage, tendons, and nervous tissue. They are also characterized by the ability to affect the immune system by secretion of compounds that support the immune response directed among others against bacteria and parasites. They have properties enabling the secretion of chemical compounds that stimulate the formation of new blood vessels. All these attributes make them applicable in regenerative medicine, transplantology and in the treatment of many diseases. The umbilical cord blood and Wharton’s jelly MSCs are the sources from which MSCs are obtained. Due to the small amount of MSCs in the starting material, it is necessary to lead in vitro cultures to obtain sufficient numbers of cells that can be administered to the patient. Methods of isolation and culture of mesenchymal stem cells, including the growth medium, play a crucial role in obtaining the appropriate biological material that guarantees therapeutic success. Therefore, continuous improvement of procedures for isolating and in vitro culturing of MSCs is extremely important. The subject of the offer is a method of culturing mesenchymal stem cells using secretions from carnivorous plants, which increase cell adherence and proliferation, counteract their transformation into specialized cells, therefore, they longer maintain their pluripotency.

CNIC (TTO) from Spanish National Center for Cardiovascular Research (CNIC)

New method to improve treatment of atrial fibrillation

  • Read
  • Posted by CNIC (TTO) from Spanish National Center for Cardiovascular Research (CNIC)
  • ·
  • Patents for licensing

Researchers from the CNIC and HCSC have developed a system to guide ablation procedures in a patient-specific way in complex cases of persistent atrial fibrillation, identifying these key regions to be treated with great precision and specificity. Furthermore, it does not require additional equipment or consumables, but only software that could be implemented within any conventional electroanatomical browser, so it would not make current pulmonary vein isolation procedures more expensive, with the advantage of being able to perform patient-specific ablation in complex cases.

Simona Rataj from University of Ljubljana

Nitroxoline for prevention and treatment of coronavirus disease

  • Read
  • Posted by Simona Rataj from University of Ljubljana
  • ·
  • Patents for licensing

University of Ljubljana has repurposed Nitroxolin for the prevention and treatment of diseases caused by coronaviruses, in particular SARS-CoV-2. A significant advantage of nitroxoline over other candidate drugs for the treatment of covid-19 (repurposing drugs – amantadine, teicoplanin) is that the mechanism of action on the target has been extensively investigated. Our process can additionally generate a variety of compounds with improved antiviral activity.

Job opportunities

Introducing Innoget Jobs

Great innovation projects are built with
talented and creative people.

Reach your candidate

Trusted at organizations large and small
Innoget is the most advanced innovation network to connect with decision makers interested in investing in you. It's free.

Free to join - no credit card required

How Innoget works

A trusted innovation network that will drive your project forward

Accelerate your innovation projects with a leading-edge innovation network that will put you in front of potential partners worldwide.

Read tailored updates

Read tailored updates

Find publications and meet experts to advance your projects. Follow and contact them in a leading-edge innovation network with experts from 180+ countries in all innovation disciplines.

Get in-depth stats

Get in-depth stats

See real-time stats on your innovation network activity. Build trust. Become a global innovation influencer.

Create exposure

Create exposure

Publish your posts to search for innovative solutions, present your novel technology, bring your startup to the innovation scene, publish your research outcome and much more.

Meet brilliant experts

Meet brilliant experts

Collaborate and chat with key innovation stakeholders in all business, technology and research areas.

USABLE. SECURE. GLOBAL.

Get ready to find the right partner in 30"

Invest 30" to start building your innovation network, get business opportunities, meet global partners and fast-track your innovation projects.

10"

Sign up. It's free.

Sign in and complete your professional profile to match you with the right publications, partners and opportunities.

20"

Meet brilliant partners

Novel technologies, great startups and innovative business opportunities at one click. Meet brilliant experts worldwide.

30"

Connect and chat

Find colleagues connected to your innovation and research areas. Chat, follow them and build your innovation network.

This might help you

Frequently Asked Questions

Some queries you might have before joining Innoget, the trusted innovation network.

Is Innoget free to join?

Yes. You can sign up completely free with a free Basic account. No credit card required.

Can I operate on Innoget for free?

Yes, you can.

Have more questions? Drop us an email. One of our success managers will be back to you soon.

How many publications can I post?

You can publish unlimited publications for free.

Can I manage my privacy?

Yes. You can hide or unhide your profile and allow or prevent people from following you.